Crossject【ALCJ】銘柄情報

Crossject (ALCJ) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.712

( 3.76% )

買値

1.696

売値

1.712

出来高

224,756

平均取引量 (3 か月)

331,634 €

財務取引量

1.638 日の範囲 1.746

1.38 52 週間の範囲 2.695

時価総額

93.208M

企業価値

108.072M

前日終値

1.65

始値

1.666

時刻

1.712

最終取引時間

00:04:35

VWAP

歳入

2.57M

純利益

-10.37M

発行済株式数

54,443,789

浮動株比率 (%)

96.94%

機関投資家保有比率 (%)

1.08%

配当利回り

PER

-8.4

株価売上高倍率 (PSR)

35.32

1 株当たり利益 (EPS)

-0.19

ベータ

0.52

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisi... Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France. 詳細を表示

セクター

Health Care

業界

Health Care Equipment & Supplies

ウェブサイト

www.crossject.com

本社

Dijon, France

設立

2026

Crossject is listed in the Health Care sector of the ユーロネクスト with ticker ALCJ. The last closing price for Crossject was 1.65 €. Over the last year, Crossject shares have traded in a share price range of 1.38 € to 2.695 €.

Crossject currently has 54,443,789 shares in issue. The market capitalisation of Crossject is 93.21 € million. Crossject has a price to earnings ratio (PE ratio) of -8.40.

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS CROSSJECT Société anonyme au capital social de 5 977 067,50 Euros Siège social : 6, rue Pauline...

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale CROSSJECT met à disposition les...

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million...

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit...

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory DIJON...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.088	-4.88888888889	1.8	1.82	1.564	224695	1.68819072	DE
4	-0.216	-11.2033195021	1.928	2.03	1.564	207140	1.81025255	DE
12	-0.252	-12.8309572301	1.964	2.58	1.564	353117	2.07858828	DE
26	-0.468	-21.4678899083	2.18	2.58	1.564	319653	2.06088808	DE
52	-0.098	-5.41436464088	1.81	2.695	1.38	292957	2.07104321	DE
156	-1.978	-53.6043360434	3.69	5.96	0.7199	160110	2.22314878	DE
260	-1.188	-40.9655172414	2.9	5.96	0.7199	130371	2.53519046	DE